During a recent appearance on The Crypto Show, Daniel Krawisz—a former backend engineer with Mycelium—outlined his concerns about the wallet company's token sale conducted the previous year. The crowd
During a recent appearance on The Crypto Show, Daniel Krawisz—a former backend engineer with Mycelium—outlined his concerns about the wallet company's token sale conducted the previous year. The crowdsale aimed to distribute ownership stakes in Mycelium's platform to its user base, yet the terms failed to establish any transparent mechanism linking token valuations to the actual worth of the underlying service. Sources indicated that most proceeds went toward payroll and legal expenses, with some participants expressing frustration over minimal building efforts since the funding round concluded. Krawisz, recognized for his work alongside the Nakamoto Institute, voiced doubts about the initiative from its inception and subsequently departed after observing capital allocated toward a European getaway for the development team.
Speculation has circulated regarding potential new leadership at Mycelium, which Krawisz's statements appeared to reinforce. Dmitry 'Rassah' Murashchik, the company's community manager, pushed back against these claims when speaking with MiningPool. "Nothing was sold," Murashchik stated. "The firm remains under its creators' control with no plans for divestment beyond the 5% already transferred and potentially an additional 20% down the road."
The trip—which Krawisz characterized as a vacation—became central to his objections. "As soon as they finished raising capital, they immediately organized what was essentially a vacation in Spain for the entire engineering staff," Krawisz explained. "Nothing substantive occurred during this time. That moment crystallized my doubts—first about the token approach itself, and second about how those earnings were deployed."
Murashchik offered a competing narrative about the Spain gathering, framing it as a necessary strategic session. "We held a team assembly to plan our direction," he clarified. "Our people are dispersed globally, and leadership wanted everyone together for in-person coordination. Spain was logical because that's where our CEO happened to be, making it convenient for most of our Europe-based crew—one developer was already vacationing there. Only two staff required transatlantic flights. Expenses were actually modest, and we maintained cost discipline. Substantive work occurred: development tasks, strategic discussions, and security initiatives."
Krawisz later reflected: "I cannot calculate the trip's proportion of total funds raised, though it was probably minimal overall. What disturbed me was being part of an organization with zero revenue and no coherent path to profitability. You splurge on excursions after exiting a flourishing enterprise, not while deploying investor capital to construct something worthwhile."
Regarding company valuation, Krawisz pointed to an $80 million figure he'd encountered on Bitcoin Uncensored, calling it "absurd given the company generated just $40,000 in total historical revenue." Murashchik countered that the actual valuation was approximately $47 million—derived from the $2.353 million capital raise in exchange for 5 percent ownership. He acknowledged that staff lacked visibility into precise revenue numbers but expressed confidence in the business trajectory: "We're producing roughly $3,000 to $4,000 monthly now from near-zero baseline, and this is accelerating."
During the Spain retreat, Krawisz recalled a Mycelium executive dismissing legal counsel's warnings. The executive allegedly joked that lawyers kept threatening jail time, opposing rigid templates in favor of experimental structures. Murashchik disputed this account entirely. "That simply didn't transpire. Our leadership ensured legal professionals vetted the entire process for compliance. The substantial fees they charged unfortunately consumed considerable capital."
